Study

EORTC-26081

Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 22-Dec-2010

Data management at EORTC

No

Design

Phase 3
Randomized open label

Targeted Sample size

EORTC Groups: 200 - All Groups: 585

Protocol summary

http://clinicaltrials.gov/study/NCT00887146

NCT number

NCT00887146

EudraCT

2008-007295-14